Silverberg Bernstein Capital Management LLC boosted its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 25.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 17,550 shares of the financial services provider's stock after acquiring an additional 3,600 shares during the period. Silverberg Bernstein Capital Management LLC's holdings in MetLife were worth $1,411,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Czech National Bank lifted its holdings in MetLife by 3.7% during the second quarter. Czech National Bank now owns 137,834 shares of the financial services provider's stock worth $11,085,000 after acquiring an additional 4,864 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its holdings in MetLife by 16.1% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 2,891 shares of the financial services provider's stock worth $232,000 after acquiring an additional 400 shares in the last quarter. Persium Advisors LLC lifted its holdings in MetLife by 5.5% during the second quarter. Persium Advisors LLC now owns 8,875 shares of the financial services provider's stock worth $714,000 after acquiring an additional 463 shares in the last quarter. Goldstone Financial Group LLC lifted its holdings in MetLife by 22.6% during the second quarter. Goldstone Financial Group LLC now owns 8,577 shares of the financial services provider's stock worth $692,000 after acquiring an additional 1,581 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its holdings in MetLife by 55.8% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,198 shares of the financial services provider's stock worth $96,000 after acquiring an additional 429 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently commented on MET. Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, August 11th. Barclays boosted their price objective on shares of MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Wolfe Research set a $95.00 price objective on shares of MetLife and gave the company an "outperform" rating in a research report on Monday. Jefferies Financial Group boosted their price objective on shares of MetLife from $100.00 to $103.00 and gave the company a "buy" rating in a research report on Monday, August 11th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Eleven research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $95.55.
Get Our Latest Report on MetLife
MetLife Stock Down 0.5%
Shares of MET opened at $80.46 on Tuesday. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05. The firm has a market cap of $53.51 billion, a P/E ratio of 13.64, a price-to-earnings-growth ratio of 0.73 and a beta of 0.87. The firm's 50-day simple moving average is $78.27 and its 200 day simple moving average is $78.21. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The company had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. During the same quarter last year, the company posted $2.28 EPS. The firm's quarterly revenue was down 2.7% on a year-over-year basis. On average, analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were paid a $0.5675 dividend. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. MetLife's dividend payout ratio is 38.47%.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.